原发性中枢神经系统淋巴瘤肿瘤微环境重塑模式的空间单细胞分析
本研究对原发性中枢神经系统淋巴瘤(PCNSL)患者进行空间转录组学分析并匹配单细胞测序数据,发现肿瘤细胞可能通过「免疫压力感知模型」实现「肿瘤微环境重塑模式」,依据免疫压力将微环境重塑为屏障环境或冷环境。关键的FKBP5+肿瘤亚群负责推动肿瘤进入屏障环境,为评估PCNSL分期提供了可能途径。研究还通过空间通讯分析鉴定了重塑模式的具体机制和免疫压力感知模型的关键分子,并揭示了免疫检查点和CAR-T靶分子在免疫治疗中的时空分布与变异特征。
要点
- 肿瘤细胞可能通过「免疫压力感知模型」将微环境重塑为屏障环境或冷环境。
- FKBP5+肿瘤亚群负责推动肿瘤进入屏障环境,可能用于评估PCNSL分期。
- 空间通讯分析鉴定了重塑模式机制及免疫压力感知模型的关键分子。
核心结论
- 数据阐明了PCNSL的肿瘤微环境重塑模式,为其免疫治疗提供参考,并为其他癌症的微环境重塑机制提供建议。
研究设计与样本
- 对PCNSL患者进行空间转录组学分析,并匹配相应的单细胞测序数据。
主要发现
- 肿瘤细胞可能通过「免疫压力感知模型」实现「肿瘤微环境重塑模式」,根据免疫压力选择将微环境重塑为屏障环境或冷环境。
- 发现关键的FKBP5+肿瘤亚群负责推动肿瘤进入屏障环境,为评估PCNSL分期提供了可能途径。
- 通过空间通讯分析鉴定了肿瘤微环境重塑模式的具体机制和免疫压力感知模型的关键分子。
- 发现了免疫检查点分子和CAR-T靶分子在免疫治疗中的时空分布及变异特征。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To determine the overall tumor microenvironment (TME), characteristics, and transition mechanisms in primary central nervous system lymphoma (PCNSL), we performed spatial transcriptomics and matched the corresponding single-cell sequencing data of PCNSL patients. We found that tumor cells may achieve a "TME remodeling pattern" through an "immune pressure-sensing model", in which they could choose to reshape the TME into a barrier environment or a cold environment according to the immune pressure. A key FKBP5+ tumor subgroup was found to be responsible for pushing tumors into the barrier environment, which provides a possible way to evaluate the stage of PCNSL. The specific mechanism of the TME remodeling pattern and the key molecules of the immune pressure-sensing model were identified through the spatial communication analysis. Finally, we discovered the spatial and temporal distributions and variation characteristics of immune checkpoint molecules and CAR-T target molecules in immunotherapy. These data clarified the TME remodeling pattern of PCNSL, provided a reference for its immunotherapy, and provided suggestions for the TME remodeling mechanism of other cancers.
引用
- Xia Y, Sun T, Li G, et al. Spatial single cell analysis of tumor microenvironment remodeling pattern in primary central nervous system lymphoma. Leukemia. 2023. PMID: 37120690. doi:10.1038/s41375-023-01908-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。